NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 21 hours 54 min ago

Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity Limited Competition (U01 Clinical Trial Not Allowed)

Wed, 12/13/2017 - 10:13
Funding Opportunity RFA-AA-18-008 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites a limited competing renewal of a U01 project to evaluate the cumulative and progressive effects on brain structure and cognitive/behavioral function of combined HIV infection and alcohol abuse. This project has recruited and longitudinally tracked a large cohort of individuals with HIV infection, or alcohol abuse, or the comorbid condition. As members of this cohort are growing older and living well longer due to antiretroviral medications, this project is well suited to address several questions of current interest in the HIV-AIDS research community. These questions include the effects of coinfection with the Hepatitis C virus, the involvement of peripheral neuropathy as a factor in frailty, potential neurotoxic effects of antiretroviral medications, and interactive effects with advancing age on sensory and motor functioning.
Categories: NIH-Funding

Notice of NIAMS' Participation in PA-18-398 "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed"

Wed, 12/13/2017 - 03:26
Notice NOT-AR-18-012 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Additional Short-Term Administrative Relief to Institutions Impacted by Hurricanes Harvey, Irma, and Maria

Tue, 12/12/2017 - 11:55
Notice NOT-OD-18-114 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Request for Information on the Office of Disease Prevention Strategic Plan for Fiscal Years (FY) 20192023

Mon, 12/11/2017 - 12:09
Notice NOT-OD-18-118 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)

Mon, 12/11/2017 - 12:09
Funding Opportunity PA-18-493 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research to understand how information technology (IT) can support systematic screening and treatment of depression in cancer patients in a variety of oncology practice settings. The goals of this FOA are to: identify new, IT-enabled delivery models that support systematic screening and treatment of depression in cancer patients; test the feasibility of implementing these new delivery models in a variety of oncology practice settings, especially those serving under-served populations; and test the effectiveness of these new delivery models, and their components, in a variety of oncology practice settings, especially those serving under-served populations.
Categories: NIH-Funding

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)

Mon, 12/11/2017 - 12:08
Funding Opportunity PA-18-492 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research to understand how information technology (IT) can support systematic screening and treatment of depression in cancer patients in a variety of oncology practice settings. The goals of this FOA are to: identify new, IT-enabled delivery models that support systematic screening and treatment of depression in cancer patients; test the feasibility of implementing these new delivery models in a variety of oncology practice settings, especially those serving under-served populations; and test the effectiveness of these new delivery models, and their components, in a variety of oncology practice settings, especially those serving under-served populations.
Categories: NIH-Funding

Collaborative Research in Computational Neuroscience (CRCNS) NSFInnovative Approaches to Science and Engineering Research on Brain Function

Mon, 12/11/2017 - 12:01
Notice NOT-MH-18-012 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Reminder of Required Letter of Support for PAR-17-094 "Maximizing Investigators Research Award (R35)"

Mon, 12/11/2017 - 11:53
Notice NOT-GM-18-011 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)

Mon, 12/11/2017 - 11:36
Funding Opportunity PA-18-485 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research on a wide range of topics related to neonatal and pediatric resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, effect of resuscitation on long-term outcomes and post-resuscitation practices. Proposals can include epidemiological studies, studies utilizing fetal-neonatal animal models, computer or other information-technology-based simulations or study designs, clinical observational studies, analyses of pre-existing national or regional datasets, opportunistic studies, prospective randomized controlled trials, or any combinations thereof. It is anticipated that the results from well-conducted studies will enable translation of knowledge into evidence-based resuscitation practices ensuring a optimal short- and long-term outcomes for all newborn infants and children.
Categories: NIH-Funding

Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)

Mon, 12/11/2017 - 11:36
Funding Opportunity PA-18-491 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research on a wide range of topics related to neonatal and pediatric resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, effect of resuscitation on long-term outcomes and post-resuscitation practices. Proposals can include epidemiological studies, studies utilizing fetal-neonatal animal models, computer or other information-technology-based simulations or study designs, clinical observational studies, analyses of pre-existing national or regional datasets, opportunistic studies prospective randomized controlled trials, or any combinations thereof. It is anticipated that the results from well-conducted studies will enable translation of knowledge into evidence-based resuscitation practices ensuring a optimal short- and long-term outcomes for all newborn infants and children.
Categories: NIH-Funding

Notice of Change in Eligibility for PAR-17-094 "Maximizing Investigators Research Award (R35)"

Mon, 12/11/2017 - 11:35
Notice NOT-GM-18-012 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional)

Mon, 12/11/2017 - 10:47
Funding Opportunity PAR-18-487 from the NIH Guide for Grants and Contracts. The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.
Categories: NIH-Funding

NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed)

Mon, 12/11/2017 - 02:49
Funding Opportunity RFA-DE-18-012 from the NIH Guide for Grants and Contracts. The Dental Specialty and PhD Program (DSPP) FOA encourages applications for institutional research career development (K12) programs from organizations that propose to develop outstanding clinician scientists through an integrated program of advanced clinical training in a recognized dental specialty and supervised research training leading to a PhD in biomedical or behavioral science, or in another field applicable to dental, oral and craniofacial research. The program should accelerate the process of early career dentist scientists in achieving competencies in both clinical and research areas and facilitate the transition to an independent and productive research career dedicated to improving dental, oral and craniofacial health.
Categories: NIH-Funding

Microphysiological Systems (MPS) for Modeling Diabetes (UG3/UH3 Clinical Trial Not Allowed)

Mon, 12/11/2017 - 02:37
Funding Opportunity RFA-DK-17-035 from the NIH Guide for Grants and Contracts. NIDDK requests applications to join a new research consortium "Microphysiological Systems (MPS) for Modeling Diabetes (MPS-MOD)". NIDDK will support the development and validation of human tissue chips that closely mimic the normal physiology of key metabolic tissues, including the pancreatic islet, liver, skeletal muscle, and white adipose tissue (WAT). Experimental designs for the MPS-MOD platforms should incorporate strategies to measure pathophysiological changes associated with metabolic disease, including the impact of immune cells on metabolic dysfunction. Once developed, these multi-dimensional MPS-MOD platforms will serve as the foundation for NIDDK's advanced strategy to identify new and novel therapeutics for diabetes. The utility and validity of model systems developed under this initiative will be measured, in part, through the ability of known diabetes therapeutic agents and biomarkers to influence biology of the system, using best practices and rigorous study design. The need for high-quality, well-characterized isogenic/patient derived iPSC (induced pluripotent stem cell) lines and standardized differentiation procedures is a critical step in turning disease-specific lines into tools for discovery. In the future, iPSC-based human tissue chips could play a central role in drug development, testing, screening, drug repurposing and toxicity testing. Eventually, collections of iPSCs that capture the heterogeneity of T2D could be used to conduct "clinical trials in a dish", to discover biomarkers of response and to develop personalized treatments. An essential feature of this program will be a multidisciplinary approach that brings together basic science experts and physician scientists in stem cell biology, bioengineering, computational biology, pharmacology, liver biology, islet biology, adipose biology, metabolism and diabetes.
Categories: NIH-Funding